跳至主要内容
临床试验/DRKS00031429
DRKS00031429招募中3 期

Effects of intermittent fasting on quality of life and toleance of chemotherapy in patients with gynaecological cancers: a randomized-controlled multi-center study - IFAST

Klinik und Poliklinik für Geburtshilfe und Frauengesundheit der Universitätsmedizin Mainz0 个研究点目标入组 110 人开始时间: 2023年3月8日最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
发起方
入组人数
110

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomized controlled study
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 one(—)
性别
Female

入选标准

  • Gynaecological cancers (ovarian/endometrial/cervical/breast)
  • - BMI = 19 kg/m2
  • - Baseline ECOG Status 0-2
  • - Life expactancy of over 6 months
  • - No i.v. chemotherapy in last 3 months
  • - Planned to recieve chemotherapy with at least one topoisomeraseinhibitor or alkylating agent over a period of three months
  • - Ability to understand the meaning and effects of the trial

排除标准

  • - Simultaneaos radiationtherapy
  • - Weight loss of >10% in last 6 months
  • - Diabetes mellitus Typ I or badly managed other type
  • - Liver or renal failure
  • - Akute psychiatric diseases
  • - Myocardial infarction in past 3 months or instable heart disease
  • - Stroke or lung artery embolism in past 3 months
  • - Pregnancy or breastfeeding period
  • - Severe internal medicine comorbidities
  • - Enterostoma or short bowl syndrom
  • - Current or past eating disorders

研究者

发起方
Klinik und Poliklinik für Geburtshilfe und Frauengesundheit der Universitätsmedizin Mainz

相似试验